• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Research team

Developed and validated by a network of private and public institutes

 Institutions involved:

  • Bayer-Schering AG
  • Free University Berlin
  • Institute of Sexology and Sexual Medicine, Charité – Universitätsmedizin Berlin
  • MSD
  • Solvay Pharmaceuticals
  • TNS-Infratest, Munich
  • University of Muenster
  • University of Berlin
  • ZEG Berlin

Research teams involved:

  • Belgium (MAPI)
  • Latvia (MAPI)
  • Brazil (Carmita Abdo)
  • Lebanon (Patrick Choueiry)
  • Bulgaria (Philipp Kumanov)
  • Malaysia (Geeta Appannah)
  • Chile (Alide Salazar Molina)Mongolia (Munkhtsetsek Janlav)
  • China (Yi Qun Gu)
  • Nigeria (Akinyemi Akanni)
  • Croatia (Sandra N. Sprajc, Claire Pexman-Fieth)
  • Norway (Johan Svartberg)
  • Denmark (MAPI)
  • Netherlands (Annoesjka Novak)
  • Netherlands (MAPI)
  • Poland (MAPI)
  • English UK/USA (Lothar Heinemann, Karin Thiele)
  • Portugal (Peter Potthoff)
  • Finland (Marc Renard )
  • Romania (Dessislava Groseva, Claire Pexman-Fieth)
  • France (MAPI, Eric Myon)
  • Russia (MAPI)
  • Germany (Lothar Heinemann)
  • Slovenia (Jaro Lajovic, Claire Pexman-Fieth)
  • Hungary (Cziszer Robert, Claire Pexman-Fieth)
  • Spain (Xavier Badia, Peter Potthoff)
  • Indonesia (Akmal Taher)
  • Sweden (Peter Potthoff)
  • Italy (Giorgio Valenti, Paolo Gontero)
  • Taiwan (Ching-Yen Chen)
  • Japan (Naoki Itho)
  • Thailand (Somboon Leungwattanakij)
  • Korea (Sehyun Kim)
  • Turkey (Onder Canguven)

sidebar

Expertise

  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
    • Research team
  • Data collection instruments

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.